Chargement en cours...
Cancer Nanotechnology: The impact of passive and active targeting in the era of modern cancer biology()
Cancer nanotherapeutics are progressing at a steady rate; research and development in the field has experienced an exponential growth since early 2000’s. The path to the commercialization of oncology drugs is long and carries significant risk; however, there is considerable excitement that nanoparti...
Enregistré dans:
| Publié dans: | Adv Drug Deliv Rev |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4219254/ https://ncbi.nlm.nih.gov/pubmed/24270007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2013.11.009 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|